In Estonia, colorectal cancer screening has demonstrated significant efficacy over the past decade, successfully identifying pre-cancerous changes in 1,067 individuals and malignant tumors in 119 participants during the 2024 screening. This marks a critical moment as Estonia celebrates the 10th anniversary of the screening program, which has seen participation soar to a record 62%, a notable increase from earlier years and a rebound from the disruptions caused by the COVID-19 pandemic.

Every year, over 1,000 people are diagnosed with colorectal cancer in Estonia, with international studies showing that nearly 5% of new cases occur in individuals under 50. The rising incidence of colorectal cancer in this age group is concerning and highlights the need for increased awareness and proactive health measures. The screening program is presented as a vital tool for catching cancers at an earlier, more treatable stage, potentially preventing many cases from developing into severe illnesses.

As the program advances, there is optimism that it will lead to better health outcomes for the population and lower the colorectal cancer incidence rate. The success of this initiative underscores the value of regular health screenings and calls for ongoing public education and engagement to ensure that those eligible for screening participate, thus enhancing overall public health in Estonia.